APAC to Dominate Stem Cell Therapy Market Through 2025
Growing public awareness
related to the therapeutic potency of stem cells to drive the growth of global
stem cell therapy market
According to
TechSci Research report, “Global Stem
Cell Therapy Market By Type, By Source of Stem Cells, By Application, By
End Users, By Region, Forecast & Opportunities, 2025”, the global stem cell therapy market is expected to grow at
a formidable rate of around 12% through 2025 on account of increased awareness
about umbilical stem cell, growing demand for regenerative treatment options,
among others. Additionally, rising R&D initiatives to develop therapeutic
options for chronic diseases and increase in the approval for clinical trials
in stem cell research are further expected to spur the market during forecast years.
However, high cost of the procedure can hamper the growth of market during
forecast period. Moreover, regulatory complications and ethical & moral
framework can further restrict the growth of market.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " Global Stem Cell Therapy Market"
https://www.techsciresearch.com/report/stem-cell-therapy-market/4488.html
The global
stem cell therapy market is segmented based on type, source of stem cells,
application, end users, company and region. Based on source of stem cells, the
market can be fragmented into adipose tissue, bone marrow, neural, embryo/cord
blood derived, iPSCs and others. The embryo/cord blood derived segment is
expected to dominate the market during forecast years. This can be ascribed to
the higher totipotency and indefinite lifespan of embryonic stem cells. Based
on application, the market can be categorized into musculoskeletal, wound &
injury, cardiovascular disease (CVD), surgery, acute graft-versus-host disease,
drug discovery & development and others. The musculoskeletal segment is
expected to dominate the market during the next five years owing to the factors
such as larger number of commercialized stem cell therapy products for the
treatment of musculoskeletal disorders and the increasing prevalence of
musculoskeletal disorders.
Osiris
Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co.,
Ltd., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd.,
NuVasive, Inc., RTI Surgical, Inc., AlloSource, Thermo Fisher Scientific and others are some
of the leading players operating in global stem cell therapy market.
Download Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=4488
Customers can
also request for 10% free customization on this report.
“Asia-Pacific is expected
to witness significant growth in stem cell therapy market during the forecast
period owing to the increasing awareness amongst people pertaining to benefits
of advanced stem cell therapies in the region. Additionally, favourable
initiatives undertaken by several organizations are expected to promote
industry players to come up with innovative solutions. For instance, according
to Pharma Focus Asia, members of Asia-Pacific Economic Cooperation collaborated
with Life Sciences Innovation Forum to involve professionals having expertise
in stem cell therapies from academia and research centers to promote
developments in stem cell research. Moreover, vast research studies taking
place in countries such as Singapore and Japan are further expected to propel
the market through 2025.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Global Stem Cell Therapy Market By Type, By
Source of Stem Cells, By Application, By End Users, By Region, Forecast &
Opportunities, 2025” has evaluated
the future growth potential of global stem cell therapy market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in global stem cell therapy market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]